ProShares - UltraShort Nasdaq Biotechnology
Not enough financial coverage to compute a composite score for BIS. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.proshares.com/our-etfs/leveraged-and-inverse/bis
ProShares UltraShort Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index.
- IPO
- 2010
- HQ
- Bethesda, MD, US
Price Chart
Valuation
- Market Cap
- $2.30M
- Div Yield
- 5.08%
Performance & Tape
- 52W High
- $19.37
- 52W Low
- $7.95
- 50D MA
- $8.80
- 200D MA
- $10.44
- Beta
- -1.20
- Avg Volume
- 17.83K
Get TickerSpark's AI analysis on BIS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BIS Coverage
We haven't published any research on BIS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BIS Report →